April 2020

Publié le 01.04.2020 08:33

The following papers were published

  • Targeted cutaneous delivery of etanercept using Er:YAG fractional laser ablation. Del Río-Sancho S, Lapteva M, Sonaje K, Böhler C, Ling V, Boehncke WH, Kalia YN.
    Int J Pharm. 2020 Apr 30;580:119234. doi: 10.1016/j.ijpharm.2020.119234
  • Non-invasive targeted iontophoretic delivery of cetuximab to skin. Lapteva M, Sallam MA, Goyon A, Guillarme D, Veuthey JL, Kalia YN.
    Expert Opin Drug Deliv. 2020 Apr;17(4):589-602. doi: 10.1080/17425247.2020.1731470